Revisionist History On Health Care Reform Deal
Executive Summary
President Obama is quite literally writing his legacy on the Affordable Care Act. His account includes a telling discussion of “special interests” that reflects the current state of the relationship between the brand name industry and the Administration – but overlooks the key role that pharma played in helping make health reform happen.
You may also be interested in...
The Campaign Against Drug Pricing: Candidates Can Only Hope Voters React As Strongly As Wall Street
Wall Street remains hypersensitive to threats from Washington or the campaign trail to take action to limit prescription drug pricing. But it is still hard to see why the threat is any greater because the Clinton campaign has a “plan” to address the issue.
Health Care Reform and the Biopharma Sector: A Complete Tactical Victory
The health care reform debate was wild and wooly-but it is hard to imagine a better outcome for the biopharma sector in general and the Pharmaceutical Research & Manufacturers of America in particular. So why isn't anybody celebrating?
US FDA’s Biggest Post-COVID Challenge May Be Helped By Small Inspections Tweak In FDORA
The omnibus spending bill included dozens of reform provisions related to the US FDA. One seemingly minor change to FDA’s inspection authorities could end up being a big help to the challenges ahead in catching up after the COVID-19 pandemic.